Sefmet PG 2mg/500mg/15mg Tablet
Marketer
Meditune Healthcare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Sefmet PG 2mg/500mg/15mg Tablet
Metformin-Glimepiride-Pioglitazone 2mg/500mg/15mg tablets are a triple-combination medication managing blood glucose. This therapy complements diet and exercise to enhance glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, thus reducing blood sugar. Dosage and regimen should strictly follow your physician's instructions. Administer with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly; however, near the next scheduled dose, omit the missed one and resume the usual schedule. Never double the dose; overdose can cause hypoglycemia. Concurrent use with other antidiabetic medications, alcohol, or skipped meals may increase the risk of hypoglycemia (low blood sugar). Regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to starting treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Kidney function tests will be conducted before initiating therapy. Limit alcohol consumption as it may heighten the risk of side effects.
Primary Ingredients of Sefmet PG 2mg/500mg/15mg Tablet
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Sefmet PG 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Sefmet PG 2mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Sefmet PG 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of Sefmet PG 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Sefmet PG 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Sefmet PG 2mg/500mg/15mg Tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
How Sefmet PG 2mg/500mg/15mg Tablet works:
Sefmet PG 2mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sefmet PG 2mg/500mg/15mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Sefmet PG 2mg/500mg/15mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Sefmet PG 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Sefmet PG 2mg/500mg/15mg tablets, potentially requiring dosage modification. Consult your physician for guidance. This medication is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Sefmet PG 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. This medication is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Sefmet PG 2mg/500mg/15mg Tablet :
Should you forget a Sefmet PG 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Sefmet PG 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently